CASSAVA SCIENCES INC
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX, 78731
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX, 78731
Phone 512-501-2444
Fiscal Year End 1231
EIN 911911336
Financial Overview
FY2024
$14.20M
Total Liabilities
$253.91M
Stockholders' Equity
$128.57M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| 8-K/A Current report amendment | December 22, 2025 | View on SEC |
| 8-K Current report of material events | December 18, 2025 | View on SEC |
| 8-K Current report of material events | December 17, 2025 | View on SEC |
| 424B2 Prospectus for shelf offering | December 5, 2025 | View on SEC |
| 8-K Current report of material events | December 3, 2025 | View on SEC |
| 4 Insider stock transaction report | November 25, 2025 | View on SEC |
| 4 Insider stock transaction report | November 24, 2025 | View on SEC |
| 4 Insider stock transaction report | November 20, 2025 | View on SEC |
| S-3 Shelf registration for future offerings | November 13, 2025 | View on SEC |
Material Events
8-K Legal Issue December 23, 2025
High Impact
- Cassava Sciences Inc. settled a major class-action lawsuit for $31.25 million, resolving claims of violating federal securities laws.
- The settlement removes a significant legal cloud and uncertainty that had been hanging over the company.
8-K Legal Issue December 18, 2025
High Impact
- The U.S. Food and Drug Administration (FDA) has placed a "full clinical hold" on Cassava Sciences' planned study for simufilam for Tuberous Sclerosis Complex (TSC)-related epilepsy.
- The FDA requires Cassava Sciences to provide more information, including additional lab data, and to change the planned study design before it can proceed.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.